Related Experiment Video
Updated: Jul 19, 2026
06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
[Retinoblastoma update--therapy (Part II)].
Arkadiusz Pogrzebielski1, Carol L Shields, Bozena Romanowska-Dixon
1Katedry i Kliniki Okulistyki i Onkologii, Okulistycznej Collegium Medicum Uniwersytetu Jagiellońskiego.
Klinika Oczna
|October 6, 2006
Summary
This paper reviews current retinoblastoma treatments, focusing on the International Intraocular Retinoblastoma Classification (IIRC) for managing this eye cancer. It details various therapeutic options from chemotherapy to surgical removal.
Area of Science:
- Ophthalmology
- Pediatric Oncology
- Cancer Treatment
Context:
- Retinoblastoma is the most common primary intraocular malignancy in children.
- Accurate staging is crucial for effective treatment planning.
- The International Intraocular Retinoblastoma Classification (IIRC) provides a standardized framework.
Purpose:
- To present updated data on retinoblastoma management.
- To describe current treatment strategies guided by the IIRC.
- To offer a comprehensive overview of available therapeutic modalities.
Summary:
- Current retinoblastoma management follows the International Intraocular Retinoblastoma Classification (IIRC).
- Treatment options discussed include chemoreduction, localized therapies (chemotherapy, thermotherapy, cryotherapy, laser), radiotherapy, and enucleation.
- The choice of treatment depends on tumor classification and extent.
Impact:
- Provides clinicians with up-to-date information for optimal patient care.
- Facilitates standardized treatment approaches globally.
- Contributes to improved outcomes and eye preservation in retinoblastoma patients.
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...